European Federation of Pharmaceutical Industries and Associations

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 05 Apr 2019
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

5,503,206€

Financial year: Jan 2017 - Dec 2017

Lobbyists (Full time equivalent)

15.75 Fte (30)

Lobbyists with EP accreditation

8

High-level Commission meetings

118

Lobbying Costs over the years

  • Info

    European Federation of Pharmaceutical Industries and Associations   (EFPIA)

    EU Transparency Register

    38526121292-88 First registered on 04 Mar 2009

    Goals / Remit

    EFPIA operates as the representative organisation of the research based pharmaceutical industry in Europe. The aim of the Federation, which has no profit-making purpose, is to promote pharmaceutical discovery and development in Europe and to promote a European regulatory environment, which facilitates innovative medicinal products to the market in order to improve human health worldwide.

    In addition, EFPIA pursues a mainly scientific aim, ensuring and promoting the technological and economic development of the pharmaceutical industry in Europe. EFPIA’s activities extend to all matters of common interest to its members. In particular, it aims to foster an environment that encourages pharmaceutical research and development, manufacture in compliance with high quality standards, intellectual property protection and the introduction of regulatory requirements to allow patients rapid access to medicinal products.

    EFPIA has developed Guidance for its members and it is available on its website.

    Main EU files targeted

    Any health or pharmaceutical policy stemming from the European Institutions such as life sciences strategy, industrial policy, European Semester, Horizon Europe Research Programme, HTA policy, IP policy etc. EFPIA also follows ongoing trade negotiations and legislative files when relevant to the innovative pharmaceutical industry (such as Water Framework Directive, Welfare of animals in scientific testing etc).

    Address

    Head Office
    8 Rue Mil Neuf Cents
    Luxembourg L-2157
    LUXEMBOURG
    EU Office
    Rue du Trône 108
    Brussels 1050
    BELGIUM
  • People

    Total lobbyists declared

    30

    Employment timeLobbyists
    100%2
    75%5
    50%17
    25%6

    Lobbyists (Full time equivalent)

    15.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    8 accreditations were / are live (in bold) for the selected state of 05 Apr 2019

    Name Start date End Date
    Athina Giannoutsou 26 Jun 2024 26 Jun 2025
    Martina D'Amore 12 Jun 2024 12 Jun 2025
    Katja Standke 12 Jun 2024 12 Jun 2025
    Roberta SAVLI 12 Jun 2024 12 Jun 2025
    Laurent David Louette 26 May 2023 25 May 2024
    Thomas Allvin 01 Mar 2024 28 Feb 2025
    Martina D'Amore 27 May 2023 25 May 2024
    Athina Giannoutsou 05 Oct 2023 04 Oct 2024
    Alexandra Tamas 06 Sep 2023 05 Sep 2024
    Sophie Millar 05 Oct 2023 04 Oct 2024
    Sibilia QUILICI 18 Oct 2023 17 Oct 2024
    Nathalie Moll 13 May 2023 11 May 2024
    Kristine PEERS 15 Jul 2023 12 Jul 2024
    Athina Giannoutsou 20 Sep 2022 20 Sep 2023
    Roberta SAVLI 04 May 2023 04 May 2024
    Ms Katja STANDKE 13 Apr 2023 26 Apr 2024
    Thomas Allvin 24 Jan 2023 24 Jan 2024
    Ms Athina Giannoutou 20 Sep 2022 11 Sep 2023
    Alexandra Tamas 06 Aug 2022 05 Aug 2023
    Sophie Millar 16 Jul 2022 15 Jul 2023
    Laurent David Louette 25 May 2022 25 May 2023
    Martina D'Amore 31 May 2022 27 May 2023
    Sibilia QUILICI 31 May 2022 31 May 2023
    Ms Anna VICERE 25 May 2022 25 May 2023
    Mr Laurent David M Louette 25 May 2022 10 Jun 2022
    Mr Giacomo Borgo 24 May 2022 24 May 2023
    Nathalie Moll 24 May 2022 13 May 2023
    Roberta SAVLI 22 Apr 2022 22 Apr 2023
    Mr PEDRO MANUEL DIAS DE FIGUEIREDO PEREIRA MARQUES 22 Apr 2022 22 Apr 2023
    Alexandra Tamas 14 Aug 2021 06 Aug 2022
    Sophie Millar 24 Jul 2021 16 Jul 2022
    Mr Koen BERDEN 08 Jun 2021 08 Jun 2022
    Martina D'Amore 04 Jun 2021 31 May 2022
    Nathalie Moll 04 Jun 2021 24 May 2022
    Sibilia QUILICI 11 May 2021 11 May 2022
    Ms Anna VICERE 06 May 2021 06 May 2022
    Ms Elizabeth Maria KUIPER 05 May 2021 12 Mar 2022
    Mr Giacomo Borgo 05 May 2021 30 Apr 2022
    Kristine PEERS 05 May 2021 30 Apr 2022
    Ms Magdalena CHLEBUS 05 May 2021 30 Apr 2022
    Mr Carlos PARRY LAFONT 29 Oct 2020 05 May 2021
    Mr Koen BERDEN 15 Feb 2020 01 Mar 2021
    Ms Magdalena RODRIGUEZ DE AZERO MACHADO 04 Feb 2020 04 Feb 2021
    Ms anna swierczyna 01 Feb 2020 30 Jan 2021
    Lenka CHRISTIAENS 09 Jan 2020 09 Jan 2021
    Kristine PEERS 05 Oct 2019 03 Oct 2020
    Ms Tea Jardas 05 Oct 2019 03 Oct 2020
    Mr Giacomo Borgo 05 Oct 2019 03 Oct 2020
    Ms Sofia MARCHA 24 Aug 2019 01 Sep 2020
    Ms Anna JEDRUSIK 22 Aug 2019 31 Jan 2020
    Ms Magdalena CHLEBUS 21 Aug 2019 01 Sep 2020
    Nathalie Moll 16 Jul 2019 16 Jul 2020
    Mr Giacomo Borgo 01 Dec 2018 05 Oct 2019
    Lenka CHRISTIAENS 06 Nov 2018 06 Nov 2019
    Ms Tea Jardas 06 Nov 2018 05 Oct 2019
    Ms Sofia MARCHA 12 Sep 2018 24 Aug 2019
    Kristine PEERS 12 Sep 2018 12 Sep 2019
    Ms Anna JEDRUSIK 12 Sep 2018 22 Aug 2019
    Ms Ioana Enache 01 Aug 2018 31 Oct 2018
    Ms Magdalena CHLEBUS 18 Jul 2018 18 Jul 2019
    Nathalie Moll 08 Jun 2018 08 Jun 2019
    Ms Gabriella Seo ALMBERG 27 Oct 2017 20 Oct 2018
    Lenka CHRISTIAENS 27 Oct 2017 20 Oct 2018
    Ms Ioana Enache 31 Aug 2017 01 Aug 2018
    Ms Magda Chlebus 20 Jul 2017 06 Jul 2018
    Nathalie Moll 05 May 2017 01 May 2018
    Ms Gabriella Seo ALMBERG 28 Oct 2016 27 Oct 2017
    Ms Raquel Silva Resendes 20 Oct 2016 10 Jun 2017
    Ms Ioana Enache 22 Aug 2016 19 Aug 2017
    Ms Magda Chlebus 19 Jan 2016 18 Jan 2017
    Mr Richard Arne BERGSTRÖM 11 Dec 2015 09 Dec 2016
    Mr Brendan Barnes 27 Nov 2015 30 Nov 2016
    Ms Elise Celia Melon 25 Nov 2015 19 Nov 2016
    Ms Gabriella Seo ALMBERG 17 Oct 2015 15 Oct 2016
    Ms Raquel Silva Resendes 17 Oct 2015 14 Oct 2016
    Ms Ioana Enache 29 Jul 2015 27 Jul 2016
    Ms Gabriella Seo ALMBERG 28 Oct 2014 17 Oct 2015
    Ms Magda Chlebus 21 Jan 2015 19 Jan 2016
    Mrs Gabriella Seo ALMBERG 28 Oct 2014 27 Jan 2015
    Mr Brendan Barnes 24 Oct 2014 22 Oct 2015
    Ms Elise Celia Melon 24 Oct 2014 22 Oct 2015
    Ms Raquel Silva Resendes 22 Oct 2014 17 Oct 2015
    Ms Anna Krózser 06 Sep 2014 30 May 2015
    Mr Richard Arne BERGSTRÖM 17 Jun 2014 13 Jun 2015
    Mrs Magdalena Chlebus 06 Dec 2013 05 Dec 2014
    Mrs Gabriella Seo ALMBERG 30 Oct 2013 28 Oct 2014
    Ms Raquel Silva Resendes 30 Oct 2013 22 Oct 2014
    Mr Brendan Barnes 05 Sep 2013 04 Sep 2014
    Mrs Angela Lorena PIEDRA HERNANDEZ 11 Sep 2013 10 Sep 2014
    Mr Richard Arne BERGSTRÖM 04 Jul 2013 17 Jun 2014
    Isabelle CLAMOU 04 Apr 2013 13 Oct 2013
    Isabelle CLAMOU 07 Mar 2012 02 Apr 2013
    Mrs Gabriella Seo ALMBERG 31 Jan 2013 27 Oct 2013
    Ms Raquel Silva Resendes 23 Nov 2012 27 Oct 2013
    Mrs Gabriella Seo ALMBERG 31 Jan 2012 08 Feb 2013
    Mrs Angela Lorena PIEDRA HERNANDEZ 31 Jan 2012 08 Feb 2013
    Mr Richard Arne BERGSTRÖM 30 Jan 2012 08 Feb 2013
    Isabelle CLAMOU 07 Mar 2012 29 Mar 2013

    Complementary Information

    EFPIA’s Team is constituted of 48 employees, including 4 dedicated to Vaccines Europe and 4 dedicated to EBE, both “specialised groups” within EFPIA. As these groups are registered separately, staff dedicated to their activities are not included in the EFPIA reporting.
    EFPIA employees that are not (9) involved in activities within scope of the Register or only occasionally i.c. spending less than 10% of their work time with EU Institutions (4) are not included in the number of persons. .
    Numbers show the situation per 31 December 2017 for the financial year 2017.

    Person in charge of EU relations

    Ms Nathalie Moll (Director General)

    Person with legal responsibility

    Mr Oschmann Stefan (President)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Trade and business associations

  • Networking

    Affiliation

    BIAC
    British Chamber of Commerce
    DIA
    EACD
    EAPM
    EPC
    FAIB
    Friends of Europe
    Kangaroo Group
    TOPRA
    European Risk Forum
    THE EUROPEAN HOUSE - AMBROSETTI

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2017 - Dec 2017

    Lobbying costs for closed financial year

    5,503,206€

    Other financial info

    EFPIA recommends that, along with EFPIA, each of its constituent entities – including corporate members, member associations and members of specialised groups – register in their individual capacity.

    EFPIA, has developed Guidance to its members. The Guidance aims at supporting consistent and transparent reporting among EFPIA members, and will be made public. EFPIA Guidance followed the provisions in the renewed Interinstitutional Agreement between the European Parliament and the EU Commission, and builds on the recommendations of the Joint Transparency Register Secretariat.

    Information included in the EFPIA Registration complies with the EFPIA Guidance. EFPIA will provide detailed information upon request.

    The EFPIA specialised groups have registered separately: EBE with public ID number 768792210017-73 and Vaccines Europe (VE) with public ID number 53073567234-18. Since specialised groups have no legal responsibility, their registration is under the legal responsibility of EFPIA. However, EBE and VE will be registered as separate “subsidiaries”, with cross-referencing links.

    Constituent entities that are not included in the EU “Transparency Register” shall not be part of EFPIA delegations interacting with the EU Commission / EP.

  • EU Structures

    Groups (European Commission)

    Group of Experts on EU Trade Agreements #E03556 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3556 #Member #C#Consultation Forum on Access and benefit sharing (ABS)#E03396 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3396 #Member #C#Competent Authorities' Expert Group on the protection of animals used for scientific purposes#E02539 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2539 #Observer #C#Strategic Coordination Group for the Water Framework and Floods Directives#E00371 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=371 #Not a member #C#Chemicals#Technical Expert Group for the implementation of the Directive on the protection of animals used for scientific purposes#E02551 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2551 #Member #C#European Alcohol and Health Forum#E02224 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2224 #Member #C#Expert group on follow-up activities related to Corporate Responsibility in the field of Pharmaceuticals #E02558 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2558 #Member #C#Multistakeholder expert group to support the application of Regulation (EU) 2016/679#E03537 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=3537 #Member #C

    Groups (European Parliament)

    None

    Communication activities

    Events with European Institutions as partners on health related topics.

    Other activities

    EFPIA covers regularly the committee debates in the European Parliament and attends public hearings, conferences, roundtables that are important to the industry. EFPIA also meets regularly Members of the European Parliament and assistants to facilitate the dialogue with the policy makers.
    EFPIA has also regular interaction with the European Commission services including DG GROW, DG SANTE, DG RTD, DG TRADE, DG ENV, etc.

  • Meetings

    Meetings

    118 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 21 Mar 2024 Location Virtual
      Subject Sanctions
      Cabinet Cabinet of Commissioner Mairead Mcguinness
      Attending
      • Katherine Power (Cabinet member)
      • Patricia Reilly (Cabinet member)
    • Date 03 Apr 2023 Location Brussels
      Subject Review of EU pharmaceutical regulations
      Cabinet Cabinet of Commissioner Mairead Mcguinness
      Portfolio Financial services, financial stability and Capital Markets Union
      Attending
      • Patricia Reilly (Cabinet member)
    • Date 21 Mar 2023 Location Brussels
      Subject Revision of the pharmaceutical legislation
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Despina Spanou (Cabinet member)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 17 Mar 2023 Location Brussels
      Subject competitiveness, intellectual property protection, FTAs
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Attending
      • Kevin Keary (Cabinet member)
    • Date 16 Mar 2023 Location Brussels (VTC)
      Subject Boosting competitiveness and productivity in the EU pharmaceutical industry
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Anthony Whelan (Cabinet member)
    • Date 16 Mar 2023 Location Brussels (VTC)
      Subject Boosting competitiveness and productivity in the pharmaceutical industry -EFPIA's report
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Anthony Whelan (Cabinet member)
    • Date 10 Feb 2023 Location Brussels
      Subject employment aspects of the upcoming Pharmaceutical legislation
      Cabinet Cabinet of Commissioner Nicolas Schmit
      Portfolio Jobs and Social Rights
      Attending
      • Antoine Kasel (Cabinet member)
    • Date 10 Feb 2023 Location Brussels
      Subject Discussion of upcoming pharmaceutical package; value of predictability (IP), EU pharmaceutical product approval process, competitiveness, unmet medical needs.
      Cabinet Cabinet of Commissioner Mairead Mcguinness
      Portfolio Financial services, financial stability and Capital Markets Union
      Attending
      • Patricia Reilly (Cabinet member)
      Other Lobbyists
    • Date 09 Feb 2023 Location Brussels
      Subject Pharma package, competitiveness
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Attending
      • Caroline Boeshertz (Cabinet member)
      • Kevin Keary (Cabinet member)
    • Date 08 Feb 2023 Location Brussels
      Subject Presenting the industry’s point of view on the upcoming pharmaceutical package and on the wider competitiveness, global positioning and resilience aspects.
      Cabinet Cabinet of Commissioner Johannes Hahn
      Portfolio Budget and Administration
      Attending
      • Kyriacos Charalambous (Cabinet member)
    • Date 02 Feb 2023 Location Brussels
      Subject Overview of EFPIA’s views on revision of EU pharmaceutical legislation; regulation, competitiveness, new drug development, research and innovation activities in Europe.
      Cabinet Cabinet of Commissioner Mairead Mcguinness
      Portfolio Financial services, financial stability and Capital Markets Union
      Attending
      • Patricia Reilly (Cabinet member)
    • Date 01 Feb 2023 Location Brussels
      Subject Discussion of the upcoming pharmaceutical legislative package
      Cabinet Cabinet of Commissioner Mairead Mcguinness
      Portfolio Financial services, financial stability and Capital Markets Union
      Attending
      • Patricia Reilly (Cabinet member)
    • Date 17 Oct 2022 Location Virtual
      Subject EFPIA/EC catch-up on HERA Next meeting of the Joint Cooperation Industrial Forum
      DG Health Emergency Preparedness and Response Authority
      Attending
      • Pierre Delsaux (Director-General)
    • Date 10 Oct 2022 Location Brussels (WEBEX)
      Subject Conc. Commission proposals to revise the entire EU pharmaceutical legislation by the end of the year
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
    • Date 29 Jun 2022 Location Brussels
      Subject Pharma Strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Margaritis Schinas (Vice-President)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 29 Jun 2022 Location Brussels
      Subject Exchange of views on the upcoming pharmaceutical legislation
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
    • Date 11 May 2022 Location on-line meeting
      Subject Exchange of views on the upcoming pharmaceutical strategy.
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Giorgios Rossides (Cabinet member)
      • Karolina Herbout-Borczak (Cabinet member)
    • Date 06 May 2022 Location Online
      Subject European Health Data Space, Data Act, Data Governance Act
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Attending
      • Werner Stengg (Cabinet member)
    • Date 29 Mar 2022 Location online meeting
      Subject access to medicines online portal
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Despina Spanou (Cabinet member)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 16 Mar 2022 Location Brussels (virtual via Webex)
      Subject  EU Pharmaceutical Strategy
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 14 Mar 2022 Location Webex
      Subject Meeting with EFPIA, Medicines for Europe and European Fine Chemical Group to discuss the security of supply of medicines
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Karolina Herbout-Borczak (Cabinet member)
      • Stella Kyriakides (Commissioner)
    • Date 26 Oct 2021 Location Brussels
      Subject Pharmaceutical sector – trade related issues
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Attending
      • Caroline Boeshertz (Cabinet member)
      • Elina Melngaile (Cabinet member)
      • Kevin Keary (Cabinet member)
      Other Lobbyists
    • Date 21 Jun 2021 Location Brussels
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Margaritis Schinas (Vice-President)
    • Date 16 Jun 2021 Location online
      Subject Supply chains for medicines
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Margaritis Schinas (Vice-President)
      Other Lobbyists
    • Date 07 Jun 2021 Location Brussels
      Subject VTC meeting - Access to Medicines
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 17 May 2021 Location Video conferencing
      Subject EU vaccine policy
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Attending
      • Michael Hager (Cabinet member)
      • Caroline Boeshertz (Cabinet member)
      • Cristina Rueda Catry (Cabinet member)
    • Date 08 Apr 2021 Location online
      Subject Health Union
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Catherine Sustek (Cabinet member)
      • Margaritis Schinas (Vice-President)
      Other Lobbyists
    • Date 25 Mar 2021 Location virtual meeting
      Subject Biopharmaceutical CEO Roundtable
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Despina Spanou (Cabinet member)
      • Maria Luisa Llano Cardenal (Cabinet member)
    • Date 05 Mar 2021 Location Brussels
      Subject VC Meeting discussion on COVID-19 vaccines export authorisation scheme.
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 12 Feb 2021 Location Brussels (virtual)
      Subject Phone call with EFPIA
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 06 Nov 2020 Location Brussels - virtual
      Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 23 Oct 2020 Location VTC
      Subject Stronger “European health union”
      Cabinet Cabinet of Commissioner Olivér Várhelyi
      Portfolio Neighbourhood and Enlargement
      Attending
      • Szabolcs Horvath (Cabinet member)
    • Date 22 Oct 2020 Location Brussels (Webex)
      Subject Exchange of views on the upcoming pharmaceutical strategy
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Giorgios Rossides (Cabinet member)
      • Karolina Herbout-Borczak (Cabinet member)
      Other Lobbyists
    • Date 20 Oct 2020 Location Virtual meeting
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Despina Spanou (Cabinet member)
    • Date 15 Oct 2020 Location Online meeting
      Subject Conference on the Future of Europe Health and industrial policies
      Cabinet Cabinet of Vice-President Dubravka Šuica
      Portfolio Democracy and Demography
      Attending
      • Mattia De Grassi (Cabinet member)
      • Astrid Dentler (Cabinet member)
    • Date 06 Oct 2020 Location Brussels
      Subject Pharmaceuticals strategy, Industrial strategy and trade policy issues
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Attending
      • Nele Eichhorn (Cabinet member)
    • Date 30 Sep 2020 Location Online
      Subject Call with pharmaceutical and medical device supply Chain on COVID-19
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Karolina Herbout-Borczak (Cabinet member)
      • Stella Kyriakides (Commissioner)
      • Giorgios Rossides (Cabinet member)
      Other Lobbyists
    • Date 23 Sep 2020 Location Webex
      Subject Meeting on the upcoming Pharmaceutical Strategy.
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Karolina Herbout-Borczak (Cabinet member)
      Other Lobbyists
    • Date 23 Sep 2020 Location Brussels (video conference)
      Subject EU pharmaceutical strategy and the general approach to IP in pharmaceuticals
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Kurt Vandenberghe (Cabinet member)
    • Date 18 Sep 2020 Location Videoconference
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Eszter Batta (Cabinet member)
    • Date 03 Jul 2020 Location Brussels
      Subject VC meeting : Exchange of views on the forthcoming Pharmaceutical Strategy
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
    • Date 29 Jun 2020 Location Online
      Subject Call with pharmaceutical and medical device industry associations on COVID-19
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Giorgios Rossides (Cabinet member)
      • Karolina Herbout-Borczak (Cabinet member)
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 29 Jun 2020 Location Brussels
      Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 10 Jun 2020 Location Brussels
      Subject Webex meeting upon EFPIA’s request to discuss the forthcoming Pharmaceutical Strategy, the evaluation of the EU Orphan Medicinal Products and Paediatrics regulations and the proposed HTA regulation
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Giorgios Rossides (Cabinet member)
      • Karolina Herbout-Borczak (Cabinet member)
    • Date 08 Jun 2020 Location Videoconference
      Subject Exchange of views on the new pharmaceutical strategy for Europe
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Maria Luisa Llano Cardenal (Cabinet member)
      • Despina Spanou (Cabinet member)
    • Date 05 Jun 2020 Location Brussels (virtual meeting)
      Subject pharmaceutical strategy of the Commission, SWD on the Orphan and Paediatric Regulation
      DG Health and Food Safety
      Attending
      • Anne Bucher (Director-General)
    • Date 29 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 19 May 2020 Location Videomeeting
      Subject To discuss EU Pharmaceutical Strategy and EU Chemical Strategy and cooperation on green agenda.
      Cabinet Cabinet of Commissioner Virginijus Sinkevičius
      Portfolio Environment, Oceans and Fisheries
      Attending
      • Camilla Bursi (Cabinet member)
      • Virginijus Sinkevičius (Commissioner)
    • Date 15 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 08 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 08 May 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 05 May 2020 Location Phone call
      Subject courtesy call and presentation by EFPIA of their concerns due to COVID crisis and the future of pharmaceutical industry
      DG Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Kerstin Jorna (Director-General)
    • Date 29 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 29 Apr 2020 Location Videconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 24 Apr 2020 Location Brussels
      Subject Covid-19
      DG Research and Innovation
      Attending
      • Jean-Eric Paquet (Director-General)
    • Date 23 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 23 Apr 2020 Location Videconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 17 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 09 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 09 Apr 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 03 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 03 Apr 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 02 Apr 2020 Location Brussels (phone call)
      Subject update on Pharma Strategy
      DG Health and Food Safety
      Attending
      • Anne Bucher (Director-General)
    • Date 27 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 27 Mar 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 20 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 20 Mar 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 13 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 28 Feb 2020 Location Brussels
      Subject EFPIA requested a meeting to present their ongoing work
      Cabinet Cabinet of Commissioner Jutta Urpilainen
      Portfolio International Partnerships
      Attending
      • Renaud Savignat (Cabinet member)
    • Date 11 Feb 2020 Location Brussels, Belgium
      Subject Health In humanitarian aid and in crisis management
      Cabinet Cabinet of Commissioner Janez Lenarčič
      Portfolio Crisis Management
      Attending
      • Kasia Jurczak (Cabinet member)
    • Date 11 Feb 2020 Location Brussels, Belgium
      Subject Pharmaceutical strategy
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Olympia Neocleous (Cabinet member)
    • Date 06 Feb 2020 Location Brussels
      Subject Medical innovation & Reform policies
      Cabinet Cabinet of Commissioner Elisa Ferreira
      Portfolio Cohesion and Reforms
      Attending
      • Marlene Madsen (Cabinet member)
    • Date 23 Jan 2020 Location Brussels
      Subject presentation EFPIA's manifesto
      Cabinet Cabinet of Commissioner Phil Hogan
      Portfolio Agriculture &amp; Rural Development
      Attending
      • Dermot Ryan (Cabinet member)
    • Date 23 Jan 2020 Location Brussels
      Subject Integrated health solutions, active ageing, sustainability and quality of healthcare systems, long-term visions on healthcare
      Cabinet Cabinet of Vice-President Dubravka Šuica
      Portfolio Democracy and Demography
      Attending
      • Astrid Dentler (Cabinet member)
    • Date 23 Jan 2020 Location Brussels
      Subject presentation EFPIA's manifesto
      Cabinet Cabinet of Commissioner Phil Hogan
      Attending
      • Dermot Ryan (Cabinet member)
    • Date 29 Aug 2019 Location Brussels
      Subject EFPIA position on the EU preliminary list of US products considered for countermeasures
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Arunas Ribokas (Cabinet member)
    • Date 29 Aug 2019 Location Brussels
      Subject Trade in the pharma sector
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Miguel Ceballos Baron (Cabinet member)
    • Date 23 Jul 2019 Location BREY-Brussels
      Subject Present their latest Manifesto and introduce the pharmaceutical companies position towards new Commission
      DG Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Timo Pesonen (Acting Director-General)
    • Date 26 Jun 2019 Location Brussels
      Subject Access to medicines, shortages, medicines for rare diseases and children
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Arunas Vinciunas (Cabinet member)
      • Alina Timofte (Cabinet member)
    • Date 25 Jun 2019 Location Brussels
      Subject development of a High-level Forum on Healthcare; the Commission "outcomes" agenda; EU HTA Regulation proposal
      DG Health and Food Safety
      Attending
      • Anne Bucher (Director-General)
    • Date 23 Apr 2019 Location BRUSSELS
      Subject PPPs in health area
      DG Research and Innovation
      Attending
      • Jean-Eric Paquet (Director-General)
    • Date 04 Feb 2019 Location Brussels
      Subject Supplementary Protection Certificate Manufacturing Waiver in Europe and EFPIA’s priorities in the context of the 2019 institutional changes
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Jyrki Katainen (Vice-President)
    • Date 03 Dec 2018 Location Brussels, Belgium
      Subject courtesy visit
      DG Health and Food Safety
      Attending
      • Anne Bucher (Director-General)
    • Date 07 Sep 2018 Location Brussels
      Subject Partnesrhips
      DG Research and Innovation
      Attending
      • Jean-Eric Paquet (Director-General)
    • Date 15 Jun 2018 Location Brussels, Berl
      Subject HTA
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
      Other Lobbyists
    • Date 19 Apr 2018 Location Brussels
      Subject Competitiveness of the European Pharmaceutical industry
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Risto Artjoki (Cabinet member)
    • Date 21 Mar 2018 Location Brussels
      Subject competitiveness of the life science industry in Europe
      Cabinet Cabinet of Vice-President Günther Oettinger
      Portfolio Budget &amp; Human Resources
      Attending
      • Michael Hager (Cabinet member)
    • Date 19 Mar 2018 Location Brussels
      Subject Health in development cooperation
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Attending
      • Nils Behrndt (Cabinet member)
    • Date 15 Mar 2018 Location Brussels
      Subject Research & Innovation policy
      Cabinet Cabinet of Commissioner Tibor Navracsics
      Portfolio Education, Culture, Youth and Sport
      Attending
      • Patricia Reilly (Cabinet member)
    • Date 08 Feb 2018 Location Brussels
      Subject Possible change of EU patent legislation
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Maria Asenius (Cabinet member)
      • Nele Eichhorn (Cabinet member)
    • Date 30 Jan 2018 Location Brussels
      Subject Exchange of views on current topics
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Fabrice Comptour (Cabinet member)
      • Elżbieta Bieńkowska (Commissioner)
    • Date 17 Jan 2018 Location Brussels
      Subject Role of pharmaceutical industry in development cooperation
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Attending
      • Nils Behrndt (Cabinet member)
      • Irena Andrassy (Cabinet member)
    • Date 12 Jan 2018 Location Brussels
      Subject Discussion on AMR
      DG Health and Food Safety
      Attending
      • Xavier Prats Monné (Director-General)
    • Date 15 Dec 2017 Location BRUSSELS
      Subject AMR; Pharma
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
    • Date 29 Nov 2017 Location Brussels
      Subject Pharmaceutical incentives, antimicrobial resistance
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
      Other Lobbyists
    • Date 27 Oct 2017 Location BRUSSELS
      Subject Meeting with the Task Force for the Preparation and Conduct of the Negotiations with the United Kingdom under Article 50 TEU
      DG Task Force for Relations with the United Kingdom
      Attending
      • Michel Barnier (Head of Task Force)
      Other Lobbyists
    • Date 29 Jun 2017 Location Brussels
      Subject Turkey - in breach of rules; Canada - some concerns around implementing legislation.
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Christian Burgsmueller (Cabinet member)
      • Maria Asenius (Cabinet member)
    • Date 24 Apr 2017 Location Brussels
      Subject Follow-up to COUNCIL conclusions: Impact of the incentives on innovation, availability and accessibility of medicinal products
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
    • Date 31 Jan 2017 Location Brussels
      Subject Non Communicable diseases
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
    • Date 07 Dec 2016 Location Brussels
      Subject Meeting with EPFIA'S President, IMI/Innovation Policy
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Carlos Moedas (Commissioner)
      • Giulia Del Brenna (Cabinet member)
    • Date 07 Oct 2016 Location Brussels, Belgium
      Subject GDPR
      Cabinet Cabinet of Commissioner Věra Jourová
      Portfolio Justice, Consumers and Gender Equality
      Attending
      • Kevin O'Connell (Cabinet member)
    • Date 15 Jun 2016 Location Brussels
      Subject HTA, AMR, Access to innovative medicines
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
    • Date 03 Jun 2016 Location Brussels
      Subject AMR, Situation in Ukraine
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
    • Date 24 Feb 2016 Location Brussels
      Subject TTIP, CETA, affordable medicines
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Cecilia Malmström (Commissioner)
    • Date 24 Feb 2016 Location Brussels
      Subject Access to Medicines, HTA, AMR
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
    • Date 24 Feb 2016 Location Brussels
      Subject Big Data, ehealth
      DG Günther Oettinger
      Attending
      • Günther Oettinger (Commissioner)
    • Date 23 Feb 2016 Location Brussels, Belgium
      Subject Access to health care and pharmaceuticals in developing countries
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Attending
      • Nils Behrndt (Cabinet member)
    • Date 25 Nov 2015 Location Brussels
      Subject AMR
      DG Health and Food Safety
      Attending
      • Xavier Prats Monné (Director-General)
    • Date 19 Nov 2015 Location Brussels
      Subject TTIP
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Miguel Ceballos Baron (Cabinet member)
      • Maria Asenius (Cabinet member)
      Other Lobbyists
    • Date 28 May 2015 Location Brussels, Belgium
      Subject Developments of pharmaceutical industry
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Arunas Vinciunas (Cabinet member)
    • Date 22 Apr 2015 Location Brussels
      Subject Trade relations with US and China
      DG Trade
      Attending
      • Jean-Luc Demarty (Director-General)
    • Date 25 Feb 2015 Location Brussels
      Subject Trade negotiations and health
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Cécile Billaux (Cabinet member)
    • Date 10 Feb 2015 Location Brussels
      Subject Science and innovation
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Antonio Lowndes Marques De Araujo Vicente (Cabinet member)
    • Date 10 Feb 2015 Location Brussels
      Subject TTIP
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Miguel Ceballos Baron (Cabinet member)
      • Maria Asenius (Cabinet member)
    • Date 26 Jan 2015 Location Brussels, Belgium
      Subject Anti-biotic resistance within development policy
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Attending
      • Paolo Berizzi (Cabinet member)
    • Date 23 Jan 2015 Location Brussels, Belgium
      Subject EFPIA engagement in developing countries
      Cabinet Cabinet of Vice-President Neven Mimica
      Portfolio International Cooperation &amp; Development
      Attending
      • Nils Behrndt (Cabinet member)
    • Date 19 Dec 2014 Location Brussels
      Subject Innovative Medecines Initiative / Ebola crisis
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Giulia Del Brenna (Cabinet member)
    • Date 18 Dec 2014 Location Brussels
      Subject European industry’s perspective on the future of EU research and innovation policy
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Carlos Moedas (Commissioner)
Download this datacard